Healius Limited
Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patie… Read more
Healius Limited (PHCRF) - Total Liabilities
Latest total liabilities as of June 2025: $1.19 Billion USD
Based on the latest financial reports, Healius Limited (PHCRF) has total liabilities worth $1.19 Billion USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Healius Limited - Total Liabilities Trend (2016–2025)
This chart illustrates how Healius Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Healius Limited Competitors by Total Liabilities
The table below lists competitors of Healius Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Verve Group SE
PINK:MGIMF
|
USA | $804.09 Million |
|
Kimball Electronics
NASDAQ:KE
|
USA | $504.31 Million |
|
Jinneng Science&Tech Co Ltd
SHG:603113
|
China | CN¥11.17 Billion |
|
CGG SA
LSE:0RI9
|
UK | €2.17 Billion |
|
Hubei Heyuan Gas Co Ltd
SHE:002971
|
China | CN¥4.12 Billion |
|
Metropole Tv
OTCGREY:MTPVY
|
USA | $641.40 Million |
|
Yunnan Nantian Electronics Information Co Ltd
SHE:000948
|
China | CN¥5.52 Billion |
|
Tianneng Power International Limited
PINK:TIANF
|
USA | $35.61 Billion |
Liability Composition Analysis (2016–2025)
This chart breaks down Healius Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.56 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.02 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.67 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Healius Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Healius Limited (2016–2025)
The table below shows the annual total liabilities of Healius Limited from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | $1.19 Billion | -38.77% |
| 2024-06-30 | $1.94 Billion | -9.54% |
| 2023-06-30 | $2.15 Billion | -3.08% |
| 2022-06-30 | $2.22 Billion | +15.08% |
| 2021-06-30 | $1.92 Billion | -26.95% |
| 2020-06-30 | $2.64 Billion | +103.43% |
| 2019-06-30 | $1.30 Billion | -0.92% |
| 2018-06-30 | $1.31 Billion | +5.01% |
| 2017-06-30 | $1.25 Billion | +4.02% |
| 2016-06-30 | $1.20 Billion | -- |